ASCO ‘In Step’ With The March to End Cancer
WASHINGTON--The American Society of Clinical Oncology (ASCO) has announced its support of "The March . . . Coming Together to Conquer Cancer," which will take place in the nation’s capital, and in dozens of US communities, on Saturday, September 26.
WASHINGTON--The American Society of Clinical Oncology (ASCO) has announced its support of "The March . . . Coming Together to Conquer Cancer," which will take place in the nations capital, and in dozens of US communities, on Saturday, September 26.
Celebrities will join ASCO and hundreds of thousands of cancer survivors, families, and concerned citizens in the weekend events in Washington, which include a rally on the Mall, a candlelight vigil, and a number of public displays. Events in other cities will include town hall meetings, rallies, health fairs, and seminars. The goal is to rally support for increased funding for cancer research, education, and prevention, and to promote access to quality cancer care for all.
![We must work on clinical predictors based on the disease phenotype, we must work on the physician’s attitude, and [we must work to] stimulate the correct and timely usage of ruxolitinib.](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fcancernetwork%2Fd5a069c33bbfe917bc7c0b1bb13d76c0a815cc44-234x234.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "We must work on clinical predictors based on the disease phenotype, we must work on the physician’s attitude, and [we must work to] stimulate the correct and timely usage of ruxolitinib.")
